[1] 刘曼曼, 管一春, 刘文霞, 等. 不同促排卵方案对卵巢储备功能减退患者体外受精-胚胎移植结局的影响[J]. 新乡医学院学报, 2019, 36(6): 529.
[2] 孙晓华, 李红梅. 腹腔镜卵巢囊肿剥除术中的两种止血方式对患者卵巢储备功能的影响[J]. 贵州医科大学学报, 2019, 44(10): 1.
[3] KARLBERG S, TⅡTINEN A, ALFTHAN H, et al. Premature ovarian insufficiency and early depletion of the ovarian reserve in the monogenic Mulibrey nanism disorder[J]. Hum Reprod, 2018, 33(7): 1254. doi: 10.1093/humrep/dey103
[4] 闵爱萍, 吴羽. 腹腔镜卵巢子宫内膜异位囊肿剥除术联合亮丙瑞林对卵巢子宫内膜异位囊肿患者卵巢储备功能的影响[J]. 中国医药导报, 2018, 15(18): 68.
[5] 郭小玲. 腹腔镜下卵巢子宫内膜异位囊肿剔除对患者卵巢储备功能的影响研究[J]. 中国医药科学, 2016, 6(10): 57.
[6] VINCENTELLI C, MARANINCHI M, VALERO R, et al. One-year impact of bariatric surgery on serum anti-Mullerian-hormone levels in severely obese women[J]. J Assist Reprod Genet, 2018, 35(7): 1317. doi: 10.1007/s10815-018-1196-3
[7] GLUCK O, TAMAYEV L, TOREM M, et al. The impact of salpingectomy on anti-mullerian hormone levels and ovarian response of in vitro fertilization patients[J]. Isr Med Assoc J, 2018, 20(8): 509.
[8] HAMZA RT, MIRA MF, HAMED AI, et al. Anti-Mullerian hormone levels in patients with turner syndrome: Relation to karyotype, spontaneous puberty, and replacement therapy[J]. Am J Med Genet A, 2018, 176(9): 1929. doi: 10.1002/ajmg.a.40473
[9] 徐秋红, 吴斯瑶, 孙国丽, 等. 经阴道三维超声自动容积测量技术联合女性基础激素及抗苗勒管激素测定在卵巢储备功能评估中的应用价值[J]. 中国医学创新, 2017, 14(35): 59. doi: 10.3969/j.issn.1674-4985.2017.35.016
[10] 庄丽丽, 丛建香, 戴皇冠, 等. 国产注射用重组人卵泡刺激素在不同卵巢储备功能患者长方案控制性超促排卵中的疗效观察[J]. 中国实用妇科与产科杂志, 2019, 35(8): 924.
[11] VERMEULEN RFM, BEURDEN M, GAARENSTROOM KN, et al. Does anti-Mullerian hormone predict change in menopausal symptoms following risk-reducing salpingo-oophorectomy: a prospective observational study[J]. Climacteric, 2018, 21(6): 574. doi: 10.1080/13697137.2018.1512965
[12] 高照猛, 徐建, 张磊, 等. 抗苗勒管激素水平评价生育期女性类风湿关节炎患者卵巢储备功能的临床意义[J]. 中国现代医生, 2018, 56(14): 21.
[13] ZHONG Y, LIN Y, CHENG XQ, et al. GnRHa for ovarian protection and the association between AMH and ovarian function during adjuvant chemotherapy for breast cancer[J]. J Cancer, 2019, 10(18): 4278. doi: 10.7150/jca.31859
[14] CANDIANI M, OTTOLINA J, POSADZKA E, et al. Assessment of ovarian reserve after cystectomy versus 'one-step' laser vaporization in the treatment of ovarian endometrioma: a small randomized clinical trial[J]. Hum Reprod, 2018, 33(12): 2205.
[15] XUE C, WEI WW, SUN P, et al. Pretreatment anti-Mullerian hormone-based nomogram predicts menstruation status after chemotherapy for premenopausal women with hormone receptor-positive early breast cancer[J]. Breast Cancer Res Tr, 2019, 173(3): 619. doi: 10.1007/s10549-018-4997-2
[16] 李再仪, 游泽山, 罗宋, 等. 抗苗勒管激素在腹膜型子宫内膜异位症患者卵巢储备功能评估中的价值研究[J]. 新医学, 2018, 49(2): 129. doi: 10.3969/j.issn.0253-9802.2018.02.012
[17] WANG SY, WANG S. Anti-Mullerian hormone as a new marker of the ovarian reserve function preservation by goserelin during (neo)adjuvant chemotherapy for young breast cancer patients[J]. J Peking Univ Health Sci, 2019, 51(3): 536.
[18] CHEN R, XIONG W, LUO XY, et al. Association of gene polymorphisms in the anti-Mullerian hormone signalling pathway with ovarianfunction: a systematic review and meta-analysis[J]. Reprod BioMed Online, 2019, 39(3): 513. doi: 10.1016/j.rbmo.2019.04.010
[19] 曾辛, 段颖卿, 徐静, 等. 卵巢子宫内膜异位囊肿患者术前应用促性腺激素释放激素激动剂的临床研究[J]. 中国现代医学杂志, 2018, 28(13): 109. doi: 10.3969/j.issn.1005-8982.2018.13.020
[20] 王雪, 李秋圆, 张少娣, 等. 卵巢储备功能评估指标对高卵泡刺激素人群体外受精-胚胎移植结局预测的研究[J]. 中华生殖与避孕杂志, 2018, 38(12): 1009.
[21] IWASE A, OSUKA S, GOTO M, et al. Clinical application of serum anti-Mullerian hormone as an ovarian reserve marker: A review of recent studies[J]. J Obstet Gynaecol Res, 2018, 44(6): 998. doi: 10.1111/jog.13633
[22] 王茜, 吴敏, 孙健. 血清抗苗勒氏管激素早期预测不孕症妇女妊娠结局的临床研究[J]. 湖南师范大学学报(医学版), 2019, 16(2): 22.
[23] 唐移忠, 许秀玲, 闫冬梅. 血清基础抗苗勒管激素和抑制素B与卵巢储备功能的关系及其临床价值分析[J]. 中国医药科学, 2018, 8(19): 214. doi: 10.3969/j.issn.2095-0616.2018.19.061
[24] 郑建波, 李艳, 夏尊恩. 联合检测抗苗勒管激素和性激素对卵巢储备功能评估的临床价值[J]. 分子诊断与治疗杂志, 2018, 10(6): 400. doi: 10.3969/j.issn.1674-6929.2018.06.009